{"nct_id":"NCT06103864","title":"A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-11-23","start_date_type":"ACTUAL","primary_completion_date":"2026-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}